OVERVIEW Rheumatologists, pulmonologists, NPs, PAs, fellows and residents who have been in practice for less than 10 years with an interest in interstitial lung diseases (ILDs) are invited to attend the 2025 Early Career Professional Program on Interstitial Lung Disease (ECPP-ILD). …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …
Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, …
The therapeutic armamentarium for inflammatory bowel disease (IBD) is expanding with the advent of anti–IL-23 therapies. The unique clinical profiles of new and emerging agents make it necessary that treatment decisions are guided by evolving knowledge of the science surrounding …
Individuals who are neurodivergent face disparities in quality of care, communication access, and employment, particularly nonverbal individuals and those with intellectual disabilities. Implicit bias and limited access to key services exacerbate these challenges. Executive functioning, sensory differences, and anxiety can …
Neurodiversity emphasizes diverse ways of thinking, learning, and behaving, and posits that people interact with their surroundings in many ways, with differences being strengths versus deficits. Health care professionals (HCPs) can improve outcomes for individuals who are neurodivergent by focusing …
Obesity care is an ongoing concern for clinicians and caregivers, particularly those who care for individuals in communities with limited resources and higher rates of overlapping comorbidities. Compounding these concerns are the forms of bias that can affect care for …
It is critical that health care professionals (HCPs) address disparities associated with obesity, which is strongly linked to cardiometabolic comorbidities such as cardiovascular disease (CVD), diabetes, hypertension, and dyslipidemia – conditions that affect individuals across various populations. While increasingly effective …
Generalized myasthenia gravis (gMG) is a chronic neuromuscular disorder that results from destruction of the neuromuscular junction by pathogenic autoantibodies, partially through the actions of the neonatal Fc receptor (FcRn). Traditional therapies only partially alleviate the heavy disease burden and …